Abstract
Study design: A randomized, prospective, double-blind, placebo-controlled clinical trial.
Objectives: To determine the effect of indomethacin on the prevention of heterotopic ossification (HO) following spinal cord injury (SCI).
Setting: County Hospital, Miami, Florida, USA.
Methods: Sixteen patients were treated with slow-release indomethacin 75 mg daily and 17 patients received placebo for a period of 3 weeks. Prevention was started 21±14 days after SCI. In both groups of patients there was similar age of the patients as well as the level of SCI and ASIA impairment scale. Two methods were used to diagnose HO, bone scintigraphy and radiographic examination. Bone scintigraphy with technetium labeled methylene-diphosphonate was used for diagnosis of early stage, while radiography was used for diagnosis of late stage of HO development.
Results: A significantly lower incidence of early HO was found in the indomethacin group (25%) than in the placebo group (65%; P<0.001). Similarly there was a significant reduction of late HO in the indomethacin group (12.5%) as compared to the placebo group (41%; P<0.001).
Conclusion: Our data suggest that indomethacin used during the first 2 months after SCI is effective in prevention of HO in a significant number of patients.
Spinal Cord (2001) 39, 370–374.
Similar content being viewed by others
Article PDF
References
Blane CE, Perkash I . True heterotopic bone in the paralyzed patient Skel Radiol 1981 7: 21–25
Hardy AG, Dickson JW . Pathological ossification in traumatic paraplegia J Bone Joint Surg 1963 45B: 76–87
Hernandez AM et al. The para-articular ossification in our paraplegics and tetraplegics: a survey of 704 patients Paraplegia 1978 16: 272–275
Sazbon L et al. Widespread periarticular new-bone formation in long-term comatose patients J Bone Joint Surg 1981 63B: 525–528
Wittenberg R, Peschke U, Botel U . Heterotopic ossification after spinal cord injury J Bone Joint Surg 1992 74B: 215–218
Dejerine A, Cellier A . Paraosteoarthropathies of paraplegic patients by spinal cord lesion: Clinical and roentgenographic study (translated, condensed, and abridged from Ann Med 5: 497, 1918) Clin Ortho Rel Res 1991 263: 3–12
Liberson M . Soft tissue calcifications in cord lesions JAMA 1953 152: 1010–1013
Banovac K, Gonzalez F . Evaluation and management of heterotopic ossification in patients with spinal cord injury Spinal Cord 1997 35: 158–162
Banovac K, Gonzalez F, Renfree KJ . Treatment of heterotopic ossification after spinal cord injury J Spinal Cord Med 1997 20: 60–65
Garland DE . A clinical perspective on common forms of acquired heterotopic ossification Clin Ortho Rel Res 1991 263: 13–29
Perkash A et al. Persistent hypercoagulation associated with heterotopic ossification in patients with spinal cord injury long after injury has occurred Paraplegia 1993 31: 653–659
Colachis SC, Clinchot DM . The association between deep venous thrombosis and heterotopic ossification in patients with acute traumatic spinal cord injury Paraplegia 1993 31: 507–512
Banovac K, Renfree KJ, Hornicek FJ . Heterotopic ossification after brain and spinal cord injury Crit Rev Physic Rehab Med 1998 10: 223–256
Lal S, Hamilton BB, Heinemann A . Risk factors for heterotopic ossification in spinal cord injury Arch Phys Med Rehabil 1989 70: 387–390
Bravo-Payno P et al. Incidence and risk factors in the appearance of heterotopic ossification in spinal cord injury Paraplegia 1992 30: 740–745
Stover SL, Hataway CJ, Zeiger HE . Heterotopic ossification in spinal cord-injured patients Arch Phys Med Rehabil 1975 56: 199–204
Hencey JY et al. Magnetic resonance imaging examinations of gluteal decubitus in spinal cord injury patients J Spinal Cord Med 1996 19: 5–8
Stover SL, Hahn HR, Miller JM . Disodium etidronate in the prevention of heterotopic ossification following spinal cord injury (preliminary report) Paraplegia 1976 14: 146–156
Stover SL, Niemann KMV, Miller JM . Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal cord injury patients J Bone Joint Surg 1976 58A: 683–688
Kjaersgaard AP, Schmidt SA . Total hip arthroplasty. The role of antiinflammatory medication in prevention of heterotopic ossification Clin Ortho Rel Res 1991 263: 78–86
McMahon JS, Waddell JP, Matron J . Effect of short course indomethacin on heterotopic bone formation after uncemented total hip arthroplasty J Arthroplasty 1991 6: 259–264
Banovac K, Gonzalez F, Wade N, Bowker JD . Intravenous disodium etiodronate therapy in spinal cord injury patients with heterotopic ossification Paraplegia 1993 31: 660–666
Buschbacher R et al. Warfarin in prevention of heterotopic ossification Am J Phys Med Rehabil 1992 71: 86–91
Garland DE, Orwin JF . Resection of heterotopic ossification in patients with spinal cord injuries Clin Ortho Rel Res 1989 242: 169–176
Subbarao J, Nemchausky B, Gratzer M, Hines E . Resection of heteropotic ossification and didronel therapy-regaining wheelchair independence in the spinal cord injured patient J Am Paraplegia Soc 1987 10: 3–7
Freebourn T, Barber D, Able A . The treatment of immature heterotopic ossification in spinal cord injury with combination surgery, radiation and NSAIDs Spinal Cord 1999 37: 50–53
Stover SL, Niemann KMW, Tullos J . Experience with surgical resection of heterotopic bone in spinal cord injury patients Clin Ortho Rel Res 1991 263: 71–77
Schurch B, Capaul M, Valloton MB, Rossier AB . Prostaglandin E2 measurements: Their value in the early diagnosis of heterotopic ossification in spinal cord injury patients Arch Phys Med Rehabil 1997 78: 687–691
Biering-Sorenson F, Tondevold F . Indomethacin and disodium etidronate for the prevention of ressurance of heterotopic ossification after surgical resection. Two case reports Paraplegia 1993 31: 513–515
Schmidt S et al. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement J Bone Joint Surg 1988 70A: 834–838
Vane JR . Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nature 1971 231: 232–235
Kawaguchi H, Pilbeam CC, Harrison JR, Raisz LG . The role of prostaglandins in the regulation of bone metabolism Clin Orthop 1995 313: 36–46
Jee WSS, Ma YF . The in vitro anabolic actions of prostaglandins in bone Bone 1997 21: 297–304
Acknowledgements
This work was supported by a generous donation from Mrs Janice Vondra.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Banovac, K., Williams, J., Patrick, L. et al. Prevention of heterotopic ossification after spinal cord injury with indomethacin. Spinal Cord 39, 370–374 (2001). https://doi.org/10.1038/sj.sc.3101166
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.sc.3101166
Keywords
This article is cited by
-
A microCT-based platform to quantify drug targeting
European Radiology Experimental (2023)
-
Neurological heterotopic ossification: novel mechanisms, prognostic biomarkers and prophylactic therapies
Bone Research (2020)
-
When the Nervous System Turns Skeletal Muscles into Bones: How to Solve the Conundrum of Neurogenic Heterotopic Ossification
Current Osteoporosis Reports (2020)
-
Heterotopic Ossification After Spinal Cord Injury: Current Clinical Approaches
Current Physical Medicine and Rehabilitation Reports (2020)
-
Use of nonsteroidal anti-inflammatory drugs to prevent heterotopic ossification after spinal cord injury: a retrospective chart review
Spinal Cord (2019)